Correlation Between Biogen and CSPC PHARMACEUTGR

Can any of the company-specific risk be diversified away by investing in both Biogen and CSPC PHARMACEUTGR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biogen and CSPC PHARMACEUTGR into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biogen Inc and CSPC PHARMACEUTGR ADR4, you can compare the effects of market volatilities on Biogen and CSPC PHARMACEUTGR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biogen with a short position of CSPC PHARMACEUTGR. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biogen and CSPC PHARMACEUTGR.

Diversification Opportunities for Biogen and CSPC PHARMACEUTGR

0.07

Correlation Coefficient

Biogen  CSPC PHARMACEUTGR

Significant diversification

The 3 months correlation between Biogen and CSPC is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Biogen Inc and CSPC PHARMACEUTGR ADR4 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CSPC PHARMACEUTGR ADR4 and Biogen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biogen Inc are associated (or correlated) with CSPC PHARMACEUTGR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CSPC PHARMACEUTGR ADR4 has no effect on the direction of Biogen i.e., Biogen and CSPC PHARMACEUTGR go up and down completely randomly.

Pair Corralation between Biogen and CSPC PHARMACEUTGR

Assuming the 90 days horizon Biogen Inc is expected to under-perform the CSPC PHARMACEUTGR. But the stock apears to be less risky and, when comparing its historical volatility, Biogen Inc is 2.2 times less risky than CSPC PHARMACEUTGR. The stock trades about -0.08 of its potential returns per unit of risk. The CSPC PHARMACEUTGR ADR4 is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  233.00  in CSPC PHARMACEUTGR ADR4 on September 12, 2024 and sell it today you would lose (9.00) from holding CSPC PHARMACEUTGR ADR4 or give up 3.86% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Biogen Inc  vs.  CSPC PHARMACEUTGR ADR4

Biogen Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biogen Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

CSPC PHARMACEUTGR ADR4

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in CSPC PHARMACEUTGR ADR4 are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, CSPC PHARMACEUTGR reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Biogen and CSPC PHARMACEUTGR

The main advantage of trading using opposite Biogen and CSPC PHARMACEUTGR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biogen position performs unexpectedly, CSPC PHARMACEUTGR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CSPC PHARMACEUTGR will offset losses from the drop in CSPC PHARMACEUTGR's long position.

The idea behind Biogen Inc and CSPC PHARMACEUTGR ADR4 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..